| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥904.1B | ¥1039.7B | -13.0% |
| Operating Income | ¥17.0B | ¥2.9B | +481.6% |
| Ordinary Income | ¥13.0B | ¥3.1B | +311.3% |
| Net Income | ¥-24.1B | ¥0.3B | -9033.3% |
| ROE | -5.2% | 0.1% | - |
FY2026 Q3 results show revenue of 904.1 billion yen (YoY -13.0%) and operating income of 17.0 billion yen (YoY +481.6%), reflecting contracting topline offset by significant margin improvement. Ordinary income reached 13.0 billion yen (YoY +311.3%), demonstrating core profitability recovery. However, extraordinary losses of 36.4 billion yen, primarily from business divestiture losses of 34.5 billion yen, pushed net income to -24.1 billion yen compared to 0.3 billion yen in the prior year. Gross margin improved approximately 300 basis points to 22.6% from 19.6% YoY, driven by easing raw material and energy costs alongside pricing adjustments. Operating margin expanded 160 basis points to 1.88% from 0.28%, though SG&A expense ratio increased 140 basis points to 20.7%, indicating ongoing fixed cost absorption challenges amid demand weakness.
[Profitability] Operating margin of 1.88% improved 160 basis points from 0.28% YoY, with gross margin expanding approximately 300 basis points to 22.6%. Net profit margin of -2.7% deteriorated 291 basis points from 0.02% due to extraordinary losses of 36.4 billion yen. ROE of -5.2% reflects the net loss impact, with DuPont decomposition showing net margin of -2.7%, asset turnover of 0.717, and financial leverage of 2.69x. SG&A expense ratio rose 140 basis points to 20.7% as expense reduction of 6.9% lagged revenue decline of 13.0%. EBITDA margin improved approximately 150 basis points to 6.1% from 4.6% YoY. [Cash Quality] Cash and equivalents of 81.1 billion yen provide 0.92x coverage of short-term debt of 87.8 billion yen. Operating cash flow of 25.5 billion yen represents -1.05x net income coverage, indicating cash generation quality concerns amid the net loss. Operating CF to EBITDA conversion of 0.46x reflects working capital pressures, particularly accounts receivable expansion of 35.5 billion yen. [Investment Efficiency] Total asset turnover of 0.717 modestly declined from approximately 0.76 YoY as revenue contraction outpaced asset reduction. [Financial Health] Equity ratio of 37.1% decreased from 36.5% YoY, remaining in mid-range territory. Current ratio of 123.6% and quick ratio of 106.1% maintain minimum liquidity standards. Debt-to-equity of 0.72x and interest-bearing debt of 336.7 billion yen yield Debt/EBITDA of 6.13x, indicating elevated leverage. Interest coverage measured by EBIT/interest expense stands at 2.63x, requiring close monitoring.
Operating cash flow of 25.5 billion yen against net loss of 24.1 billion yen reflects non-cash charges including the business divestiture loss, though the negative earnings base raises cash quality concerns. Working capital movements exerted mixed impacts, with accounts receivable increases consuming 35.5 billion yen offset partially by accounts payable increases contributing 20.2 billion yen and inventory reductions adding 7.9 billion yen. Tax payments of 13.9 billion yen represented a significant outflow. EBITDA of 54.9 billion yen converted to operating CF at a 0.46x ratio, indicating inefficient cash realization. Investing cash flow of -38.2 billion yen comprised capital expenditures of 31.3 billion yen and subsidiary-related outlays of 27.8 billion yen associated with portfolio restructuring. Free cash flow of -12.7 billion yen indicates the company cannot self-fund both capital investment and dividend commitments from current operations. The persistent accounts receivable buildup represents a structural cash drag requiring tighter collection management and credit terms.
Ordinary income of 13.0 billion yen versus operating income of 17.0 billion yen reflects net non-operating expenses of approximately 4.0 billion yen, primarily comprising interest expense of 6.4 billion yen partially offset by non-operating income. The 36.4 billion yen extraordinary loss, dominated by the 34.5 billion yen business divestiture charge, represents a significant one-time item distorting reported net income. Non-operating expenses represent 0.7% of revenue, driven by interest and financing costs. Operating cash flow generation despite the net loss indicates the presence of substantial non-cash charges, though the negative operating CF to net income multiple and low EBITDA conversion ratio of 0.46x raise concerns about underlying earnings cash quality. Working capital deterioration, particularly the 35.5 billion yen accounts receivable increase against declining sales, suggests potential accruals pressure and collection challenges that warrant attention.
Elevated leverage position with Debt/EBITDA of 6.13x and interest coverage of 2.63x constrains financial flexibility and amplifies earnings volatility to interest rate movements. Near-term refinancing pressure from 87.8 billion yen short-term debt plus 7.0 billion yen bonds due within one year against cash holdings of 81.1 billion yen creates liquidity management risk. Working capital strain evidenced by 35.5 billion yen accounts receivable expansion amid 13.0% revenue decline signals potential collection deterioration or customer credit quality concerns requiring enhanced receivables management.
[Industry Position] (Reference - Proprietary Analysis) The company's financial metrics show significant divergence from manufacturing industry medians across multiple dimensions. Profitability metrics reveal substantial underperformance with operating margin of 1.88% well below the industry median of 7.3% (IQR: 4.6%-12.0%) and net profit margin of -2.7% versus industry median of 5.4% (IQR: 3.5%-8.9%), positioning the company in the bottom quartile. ROE of -5.2% compares unfavorably to the industry median of 4.9% (IQR: 2.8%-8.2%), while ROA performance similarly trails. Revenue growth of -13.0% underperforms the industry median of 2.8% (IQR: -0.9%-7.9%), indicating market share pressure or end-market weakness exceeding sector trends. Financial health metrics show mixed positioning with equity ratio of 37.1% below the industry median of 63.9% (IQR: 51.5%-72.3%), suggesting higher leverage relative to peers. Current ratio of 123.6% sits well below the industry median of 2.67x (IQR: 2.00x-3.56x), indicating tighter liquidity buffers. The Net Debt/EBITDA position, while not directly comparable due to the company's positive net debt versus the industry median of -1.11, reflects substantially higher leverage than the typical peer with net cash positions. Overall, the company operates with below-median profitability, weaker financial health metrics, and higher leverage compared to manufacturing industry peers, though ongoing margin recovery efforts show early progress. (Industry: Manufacturing (65 companies), Comparison: FY2025 Q3 peer group, Source: Proprietary analysis)
Core profitability inflection with gross margin expansion of 300 basis points and operating margin improvement of 160 basis points demonstrates successful cost normalization and pricing realization, providing a foundation for sustainable earnings recovery once extraordinary restructuring costs subside and revenue stabilizes. The full-year guidance of 23.5 billion yen operating income (2.7x growth) with breakeven net income and 10 yen dividend indicates management confidence in core momentum despite Q3 net loss. High leverage profile with Debt/EBITDA of 6.13x and interest coverage of 2.63x coupled with negative free cash flow of 12.7 billion yen necessitates careful monitoring of refinancing execution, working capital normalization, and deleveraging progress to ensure financial sustainability through the restructuring period and demand recovery cycle.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.